Patents by Inventor Jeffery L. Edelman

Jeffery L. Edelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
    Patent number: 8409607
    Abstract: Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.
    Type: Grant
    Filed: February 11, 2008
    Date of Patent: April 2, 2013
    Assignee: Allergan, Inc.
    Inventors: Patrick M. Hughes, Thomas C. Malone, Gerald W. De Vries, Jeffery L. Edelman, Joan-En Chang-Lin, Jane-Guo Shiah, Thierry Nivaggioli
  • Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
    Patent number: 8404267
    Abstract: Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.
    Type: Grant
    Filed: February 11, 2008
    Date of Patent: March 26, 2013
    Assignee: Allergan, Inc.
    Inventors: Patrick M. Hughes, Thomas C. Malone, Gerald W. De Vries, Jeffery L. Edelman, Joan-En Chang-Lin, Jane-Guo Shiah, Thierry Nivaggioli
  • SUSTAINED RELEASE INTRAOCULAR INPLANTS CONTAINING TYROSINE KINASE INHIBITORS AND RELATED METHODS
    Publication number: 20080260803
    Abstract: Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.
    Type: Application
    Filed: February 11, 2008
    Publication date: October 23, 2008
    Applicant: ALLERGAN,INC.
    Inventors: Patrick M. HUGHES, Thomas C. MALONE, Gerald W. DE VRIES, Jeffery L. EDELMAN, Joan-En CHANG-LIN, Jane-Guo SHIAH, Thierry NIVAGGIOLI
  • SUSTAINED RELEASE INTRAOCULAR IMPLANTS CONTAINING TYROSINE KINASE INHIBITORS AND RELATED METHODS
    Publication number: 20080254096
    Abstract: Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants may be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.
    Type: Application
    Filed: February 11, 2008
    Publication date: October 16, 2008
    Applicant: ALLERGAN,INC
    Inventors: Patrick M. HUGHES, Thomas C. MALONE, Gerald W. DE VRIES, Jeffery L. EDELMAN, Joan-En CHANG-LIN, Jane Guo SHIAH, Thierry NIVAGGIOLI